tirzepatide going away is compounding 🚨March 19! If you haven't heard, March 19 the How to wean off tirzepatide:

Are GLP-1 injections safe for long-term use

Published work examines actin polymerization and VEGF upregulation, frequently using scratch-wound closure and transwell migration assays as readouts

Compared to NSAIDs: No gastrointestinal toxicity No cardiac risks No kidney damage risk No drug interactions Actively promotes healing rather than masking symptoms Compared to corticosteroids: No immunosuppression No bone density loss No endocrine disruption No adrenal suppression Promotes healing rather than suppressing inflammation Compared to other peptides: Similar or better safety profile Minimal side effects No hormonal disruption Well tolerated across populations Regulatory and Ethical Considerations Researchers should be aware of the regulatory status

This lower dose is commonly prescribed for initial therapy or sensitive patients , helping begin treatment safely under medical supervision